{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:10:12Z","timestamp":1791155412585,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF)","doi-asserted-by":"crossref","award":["R01-2007-000-20475-0"],"award-info":[{"award-number":["R01-2007-000-20475-0"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"2009 Health and Medical Technology R&D program","award":["A092010"],"award-info":[{"award-number":["A092010"]}]},{"name":"2009 Health and Medical Technology R&D program","award":["A090945"],"award-info":[{"award-number":["A090945"]}]},{"name":"Rural Development Administration, South Korea","award":["20070501-034-001-009-03-00"],"award-info":[{"award-number":["20070501-034-001-009-03-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.vaccine.2010.01.013","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T11:58:39Z","timestamp":1264766319000},"page":"2598-2606","source":"Crossref","is-referenced-by-count":39,"title":["Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants"],"prefix":"10.1016","volume":"28","author":[{"given":"Hee-Jeong","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Mogg","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehoon","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.01.013_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2006.01.002","article-title":"Mucosal delivery of vaccine antigens and its advantages in pediatrics","volume":"58","author":"De Magistris","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2010.01.013_bib2","doi-asserted-by":"crossref","first-page":"e2954","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine","volume":"3","author":"Makidon","year":"2008","journal-title":"PLoS ONE"},{"issue":"10 (Suppl.)","key":"10.1016\/j.vaccine.2010.01.013_bib3","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/INF.0b013e318168b729","article-title":"Universal influenza vaccination and live attenuated influenza vaccination of children","volume":"27","author":"Glezen","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.01.013_bib4","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/IAI.73.10.6892-6902.2005","article-title":"Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract","volume":"73","author":"van Ginkel","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.01.013_bib5","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C","article-title":"Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant","volume":"32","author":"BenMohamed","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib6","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"\u00c7uburu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.01.013_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.01.013_bib9","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1158\/0008-5472.CAN-06-0630","article-title":"Prospects for cervical cancer prevention by human papillomavirus vaccination","volume":"66","author":"Schiller","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2010.01.013_bib10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1586\/14760584.7.10.1465","article-title":"AS04-adjuvanted human papillomavirus-16\/18 vaccination: recent advances in cervical cancer prevention","volume":"7","author":"Schwarz","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.01.013_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/092986607780782722","article-title":"Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein","volume":"14","author":"Cho","year":"2007","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.vaccine.2010.01.013_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JCM.27.5.947-951.1989","article-title":"Single-step, chromogenic limulus amebocyte lysate assay for endotoxin","volume":"27","author":"Lindsay","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymeth.2005.10.003","article-title":"Thermosensitive and mucoadhesive delivery systems of mucosal vaccines","volume":"38","author":"Han","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2010.01.013_bib14","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0264-410X(02)00779-X","article-title":"Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system","volume":"21","author":"Oh","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virol.2004.06.047","article-title":"Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant","volume":"328","author":"Oh","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.01.013_bib16","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/j.vaccine.2007.09.024","article-title":"Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1","volume":"25","author":"Cho","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1023\/A:1016454003450","article-title":"Biolayer films for mucosal (genetic) immunization via the buccal route in rabbits","volume":"19","author":"Cui","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2010.01.013_bib18","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.micinf.2006.07.018","article-title":"Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection","volume":"8","author":"Asahi-Ozaki","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2010.01.013_bib19","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.01.013_bib20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20052433","article-title":"Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates","volume":"203","author":"Wille-Reece","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.01.013_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","article-title":"Intracellular NOD-like receptors in host defense and disease","volume":"27","author":"Kanneganti","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.01.013_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.vaccine.2005.09.007","article-title":"Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A","volume":"24","author":"Moschos","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpendmet0716","article-title":"Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity","volume":"4","author":"Adams","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.vaccine.2010.01.013_bib24","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.4049\/jimmunol.178.5.2979","article-title":"Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity","volume":"178","author":"Uto","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmv.21029","article-title":"Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine","volume":"80","author":"Wang","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4049\/jimmunol.176.2.1122","article-title":"Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal sIgA production in response to the influenza virus antigen","volume":"176","author":"Mizuno","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jmv.10442","article-title":"Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems","volume":"70","author":"Park","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.0818-9641.2004.01285.x","article-title":"Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha\/beta","volume":"82","author":"Durand","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.vaccine.2007.11.084","article-title":"TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines","volume":"26","author":"Enioutina","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib30","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.vaccine.2009.02.029","article-title":"Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles","volume":"27","author":"Fraillery","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib31","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1128\/IAI.00508-09","article-title":"Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection","volume":"77","author":"Raman","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.01.013_bib32","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib33","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MPG.0b013e318156050d","article-title":"Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice","volume":"46","author":"Huang","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.vaccine.2010.01.013_bib35","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0264-410X(99)00337-0","article-title":"Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant","volume":"18","author":"Goto","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib36","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/IAI.71.4.1740-1747.2003","article-title":"Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development","volume":"71","author":"Eriksson","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.01.013_bib37","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.4049\/jimmunol.0803568","article-title":"CCR7-CCL19\/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination","volume":"182","author":"Song","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2004.12.008","article-title":"From toxin to adjuvant: basic mechanisms for the control of mucosal sIgA immunity and tolerance","volume":"97","author":"Lycke","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2010.01.013_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.153.2.647","article-title":"Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin","volume":"153","author":"Snider","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.01.013_bib40","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.vaccine.2008.09.019","article-title":"Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed","volume":"26","author":"Takagi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.01.013_bib41","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.4049\/jimmunol.170.3.1586","article-title":"Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses","volume":"170","author":"Anju\u00e8re","year":"2003","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T20:37:45Z","timestamp":1685392665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0264410X10000447"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.01.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}